Literature DB >> 1402682

Expression of vascular permeability factor (vascular endothelial growth factor) by epidermal keratinocytes during wound healing.

L F Brown1, K T Yeo, B Berse, T K Yeo, D R Senger, H F Dvorak, L van de Water.   

Abstract

Persistent microvascular hyperpermeability to plasma proteins even after the cessation of injury is a characteristic but poorly understood feature of normal wound healing. It results in extravasation of fibrinogen that clots to form fibrin, which serves as a provisional matrix and promotes angiogenesis and scar formation. We present evidence indicating that vascular permeability factor (VPF; also known as vascular endothelial growth factor) may be responsible for the hyperpermeable state, as well as the angiogenesis, that are characteristic of healing wounds. Hyperpermeable blood vessels were identified in healing split-thickness guinea pig and rat punch biopsy skin wounds by their capacity to extravasate circulating macromolecular tracers (colloidal carbon, fluoresceinated dextran). Vascular permeability was maximal at 2-3 d, but persisted as late as 7 d after wounding. Leaky vessels were found initially at the wound edges and later in the subepidermal granulation tissue as keratinocytes migrated to cover the denuded wound surface. Angiogenesis was also prominent within this 7-d interval. In situ hybridization revealed that greatly increased amounts of VPF mRNA were expressed by keratinocytes, initially those at the wound edge, and, at later intervals, keratinocytes that migrated to cover the wound surface; occasional mononuclear cells also expressed VPF mRNA. Secreted VPF was detected by immunofluoroassay of medium from cultured human keratinocytes. These data identify keratinocytes as an important source of VPF gene transcript and protein, correlate VPF expression with persistent vascular hyperpermeability and angiogenesis, and suggest that VPF is an important cytokine in wound healing.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1402682      PMCID: PMC2119412          DOI: 10.1084/jem.176.5.1375

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  18 in total

Review 1.  Keratinocyte cytokines.

Authors:  S Nozaki; C Feliciani; D N Sauder
Journal:  Adv Dermatol       Date:  1992

2.  Vascular permeability factor (vascular endothelial growth factor) gene is expressed differentially in normal tissues, macrophages, and tumors.

Authors:  B Berse; L F Brown; L Van de Water; H F Dvorak; D R Senger
Journal:  Mol Biol Cell       Date:  1992-02       Impact factor: 4.138

3.  Vascular endothelial growth factor is a secreted angiogenic mitogen.

Authors:  D W Leung; G Cachianes; W J Kuang; D V Goeddel; N Ferrara
Journal:  Science       Date:  1989-12-08       Impact factor: 47.728

4.  The human gene for vascular endothelial growth factor. Multiple protein forms are encoded through alternative exon splicing.

Authors:  E Tischer; R Mitchell; T Hartman; M Silva; D Gospodarowicz; J C Fiddes; J A Abraham
Journal:  J Biol Chem       Date:  1991-06-25       Impact factor: 5.157

Review 5.  The activated keratinocyte: a model for inducible cytokine production by non-bone marrow-derived cells in cutaneous inflammatory and immune responses.

Authors:  T S Kupper
Journal:  J Invest Dermatol       Date:  1990-06       Impact factor: 8.551

6.  Healing of partial thickness porcine skin wounds in a liquid environment.

Authors:  K Breuing; E Eriksson; P Liu; D R Miller
Journal:  J Surg Res       Date:  1992-01       Impact factor: 2.192

Review 7.  Tumors: wounds that do not heal. Similarities between tumor stroma generation and wound healing.

Authors:  H F Dvorak
Journal:  N Engl J Med       Date:  1986-12-25       Impact factor: 91.245

8.  Fibrinogen influx and accumulation of cross-linked fibrin in healing wounds and in tumor stroma.

Authors:  L F Brown; L Van de Water; V S Harvey; H F Dvorak
Journal:  Am J Pathol       Date:  1988-03       Impact factor: 4.307

9.  Vascular permeability factor: a tumor-derived polypeptide that induces endothelial cell and monocyte procoagulant activity, and promotes monocyte migration.

Authors:  M Clauss; M Gerlach; H Gerlach; J Brett; F Wang; P C Familletti; Y C Pan; J V Olander; D T Connolly; D Stern
Journal:  J Exp Med       Date:  1990-12-01       Impact factor: 14.307

10.  Reappearance of an embryonic pattern of fibronectin splicing during wound healing in the adult rat.

Authors:  C Ffrench-Constant; L Van de Water; H F Dvorak; R O Hynes
Journal:  J Cell Biol       Date:  1989-08       Impact factor: 10.539

View more
  210 in total

Review 1.  Influence of host microvascular environment on tumour vascular endothelium.

Authors:  M Kubitza; L Hickey; W G Roberts
Journal:  Int J Exp Pathol       Date:  1999-02       Impact factor: 1.925

2.  Glomeruloid microvascular proliferation follows adenoviral vascular permeability factor/vascular endothelial growth factor-164 gene delivery.

Authors:  C Sundberg; J A Nagy; L F Brown; D Feng; I A Eckelhoefer; E J Manseau; A M Dvorak; H F Dvorak
Journal:  Am J Pathol       Date:  2001-03       Impact factor: 4.307

3.  VEGF expression by epithelial and stromal cell compartments: resolving a controversy.

Authors:  D R Senger; L Van De Water
Journal:  Am J Pathol       Date:  2000-07       Impact factor: 4.307

4.  Expression of the oxygen-regulated protein ORP150 accelerates wound healing by modulating intracellular VEGF transport.

Authors:  K Ozawa; T Kondo; O Hori; Y Kitao; D M Stern; W Eisenmenger; S Ogawa; T Ohshima
Journal:  J Clin Invest       Date:  2001-07       Impact factor: 14.808

5.  Delayed wound healing in CXCR2 knockout mice.

Authors:  R M Devalaraja; L B Nanney; J Du; Q Qian; Y Yu; M N Devalaraja; A Richmond
Journal:  J Invest Dermatol       Date:  2000-08       Impact factor: 8.551

Review 6.  Role of vascular permeability factor/vascular endothelial growth factor in eye disease.

Authors:  R O Schlingemann; V W van Hinsbergh
Journal:  Br J Ophthalmol       Date:  1997-06       Impact factor: 4.638

7.  Rous-Whipple Award Lecture. How tumors make bad blood vessels and stroma.

Authors:  Harold F Dvorak
Journal:  Am J Pathol       Date:  2003-06       Impact factor: 4.307

Review 8.  Biocompatible materials for continuous glucose monitoring devices.

Authors:  Scott P Nichols; Ahyeon Koh; Wesley L Storm; Jae Ho Shin; Mark H Schoenfisch
Journal:  Chem Rev       Date:  2013-02-07       Impact factor: 60.622

9.  The transcription factor Net regulates the angiogenic switch.

Authors:  Hong Zheng; Christine Wasylyk; Abdelkader Ayadi; Joseph Abecassis; Jack A Schalken; Hermann Rogatsch; Nicolas Wernert; Sauveur-Michel Maira; Marie-Christine Multon; Bohdan Wasylyk
Journal:  Genes Dev       Date:  2003-09-15       Impact factor: 11.361

Review 10.  Silver nanoparticles as real topical bullets for wound healing.

Authors:  Thirumurugan Gunasekaran; Tadele Nigusse; Magharla Dasaratha Dhanaraju
Journal:  J Am Coll Clin Wound Spec       Date:  2012-06-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.